A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday. Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.
[Editor’s Note: We have added ‘Breaking‘ as a new feature because . . . Drudge has gone away.]